U.S. program targets antipsychotic drug use in nursing homes

May 30, 2012 By Steven Reinberg, HealthDay Reporter
U.S. program targets antipsychotic drug use in nursing homes
Many dementia patients getting these drugs as chemical restraints, officials say.

(HealthDay) -- U.S. health officials said Wednesday that they're hoping to reduce the use of antipsychotic drugs among nursing home residents by 15 percent before year's end.

To achieve that goal, the U.S. Centers for Medicare and Medicaid Services (CMS) said it's launching the Partnership to Improve Dementia Care. The partnership involves federal and state officials, nursing homes and other providers, and caregivers.

According to CMS, overuse of in nursing home patients suffering from dementia is a significant problem. CMS statistics indicate that in 2010, more than 17 percent of nursing home patients had daily doses exceeding recommended levels.

"We seek to ensure that nursing homes provide the best resident-centered care by creating a familiar and comfortable where residents' autonomy and choices in their personal lifestyle are honored," Dr. Shari Ling, CMS deputy chief medical officer, said during an afternoon news conference.

The goal of the program is to protect patients from unnecessary drug use, she said.

Use of antipsychotic drugs has grown and many of these drugs are used by patients diagnosed with dementia who can't always communicate their needs, Ling said.

Speaking at the news conference, Claire Curry, legal director of the Civil Advocacy Program at the Legal Aid Justice Center, said that " across the country are pleased to see CMS launch this initiative."

"The drugging of nursing home residents has long been a national disgrace," she said, adding that hundreds of thousands of long-term care residents are drugged inappropriately, costing hundreds of millions of dollars.

These drugs carry a black box warning from the U.S. that they cause death in , Curry said.

"Advocates welcome every step taken to raise awareness about the dangers, to end unnecessary drugging and the harm it brings residents and to strictly enforce rules already in place to protect residents from unnecessary drugs, especially antipsychotics being used as chemical restraints," she said.

The CMS initiative includes:

  • Training that emphasizes high-quality care for nursing home patients.
  • Making data on antipsychotic drug use at nursing homes available on the website Nursing Home Compare.
  • Suggesting alternatives to antipsychotics such as exercise, outdoor time, pain management and planned activities for patients.

Explore further: Inspector highlights psych drug use among elderly

More information: For more on dementia, visit the U.S. National Library of Medicine.


Related Stories

Inspector highlights psych drug use among elderly

November 30, 2011
(AP) -- Government inspectors will tell lawmakers Wednesday that the Medicare health plan needs to do more to stop doctors from prescribing powerful psychiatric drugs to nursing home patients with dementia, an unapproved ...

Specific antipsychotic drugs increase risk of death in elderly dementia patients

February 23, 2012
Nursing home residents over the age of 65 who take certain antipsychotic medication for dementia are at an increased risk of death, suggests a research paper published today in the British Medical Journal.

Recommended for you

Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say

December 11, 2017
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...

FDA's program to speed up drug approval shaved nearly a year off the process

December 7, 2017
Speeding the pace at which potentially lifesaving drugs are brought to market was a rallying cry for Donald Trump as a candidate, and is a stated priority of his Food and Drug Administration commissioner, Dr. Scott Gottlieb. ...

Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017
The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first ...

Surgery-related opioid doses can drop dramatically without affecting patients' pain

December 6, 2017
Some surgeons might be able to prescribe a third of opioid painkiller pills that they currently give patients, and not affect their level of post-surgery pain control, a new study suggests.

Four-fold jump in deaths in opioid-driven hospitalizations

December 4, 2017
People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by Harvard Medical School and published in the December issue of ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

DanielHaszard
not rated yet May 31, 2012
Thanks for posting this vital information.The Eli Lilly company made an astounding $65 BILLION on Zyprexa that they PUSHED on the elderly and underage children (*Viva Zyprexa* Lilly sales rep slogan) with wanton disregard for the side effects
*FIVE at FIVE*
The Zyprexa antipsychotic drug,whose side effects can include weight gain and diabetes, was sold to Veterans,children in foster care, elderly in nursing homes.
*Five at Five* was the Zyprexa sales rep slogan, meaning *5mg dispensed at 5pm would keep patients quiet*.

*Tell the truth don't be afraid*-- Daniel Haszard FMI http://www.zyprexa-victims.com

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.